Current Standards of Treatment in MS and the Role of Oral Agents
New! In this Neurology Report, learn about the efficacy and safety profiles of current MS treatments. Plus, weigh the advantages and disadvantages associated with oral medications.
Discover why antidepressant monotherapy is not recommended by current guidelines, what risks are associated with their use, and when their use is indicated.
Find out which disorders are often confused with restless legs syndrome (RLS) and which conditions and medications are associated with secondary RLS.
Measurement-Based Strategies to Assess and Manage Schizophrenia
Read this Supplement to discover how to distinguish between primary and secondary negative symptoms, find out how to assess treatment response, and review new therapeutic targets.
Do you treat your patients with MDD until they are asymptomatic? In this Supplement, find out how to recognize, monitor, and treat residual symptoms.
This Commentary summarizes an online CME program on the treatment of depression and assesses outcomes of that program.
Learn how vision problems and cognitive decline may be indicative of a variant of Alzheimer's disease.
Get an overview of core themes in troubled relationships as well as ways to assess for, prevent, and address intimate partner violence in veterans and their families.
Review the burden of and risk factors for TRD, learn how to assess for treatment resistance, and find out about current and new therapeutic strategies.
Learn about the pros and cons of LAI antipsychotics and ways to address health care team concerns.
Do you have young patients with OCD? Here, learn how developmental factors, family involvement, and co-occurring conditions affect treatment.
Find out how to assess your patients' response to treatment and recognize residual symptoms so that you can implement appropriate next-step strategies.
Update on Best Practices for Managing Bipolar Depression
New! This Commentary summarizes 2 CME activities on managing bipolar depression through using measurement-based assessments and knowing which medications are most effective.
Potential Barriers to Oral MS Medications
New! Learn about the positive and negative aspects of the 3 FDA-approved oral medications for MS including their associated risks and benefits.
Please take our online poll
Measure of Anxiety in MDD
Anxiety is high in patients with MDD. Learn about a reliable self-administered scale that measures both anxiety and depression.